Abstract
The multidimensional echocardiographic features associated with BP level are unclear. This study aimed to identify the multidimensional echocardiographic features associated with BP. In total, 2 092 adult participants (aged ≥18 years) with hypertension who underwent echocardiography in Beijing between July 2017 and January 2020 as part of the Multi-provincial Cohort for Hypertension study were enrolled. The associations between BP levels and echocardiographic features were investigated by multivariate regression analysis. After multivariable adjustment, a 1 SD (15.4 mmHg) increase in systolic BP was associated with a 0.21-mm increment (95% CI 0.06–0.35) in left atrial diameter, a 2.17-g/m2 increment (95% CI 1.46–2.88) in LV mass index, a 0.25-mm increment (95% CI 0.11–0.39) in ascending aorta diameter and a 0.03 decrement (95% CI −0.04, −0.01) in the E/A ratio. A 1 SD (10.1 mmHg) increase in diastolic BP was associated with a 1.51-g/m2 increment (95% CI 0.80–2.21) in LV mass index, a 0.46-mm increment (95% CI 0.31–0.61) in aortic root diameter, a 0.77-mm increment (95% CI 0.63–0.91) in ascending aorta diameter, and a 0.05 decrement (95% CI −0.07, −0.04) in E/A ratio. In conclusion, specific echocardiographic features were associated with the BP level. LV structure, ascending aorta diameter, and the E/A ratio were associated with systolic and diastolic BP. Left atrial diameter was positively associated only with systolic BP, and aortic root diameter was positively associated only with diastolic BP. These echocardiographic features may be valuable for early identification of target organ damage caused by elevated BP.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others
Data availability
The data generated in this research can be made available from the corresponding authors upon request.
References
NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398:957–80.
Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019;394:1145–58.
Liu J. Highlights of the 2018 Chinese hypertension guidelines. Clin Hypertens. 2020;26:8.
Zhou B, Perel P, Mensah GA, Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol. 2021;18:785–802.
Perrone-Filardi P, Coca A, Galderisi M, Paolillo S, Alpendurada F, de Simone G, et al. Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: a consensus article from the European Association of Cardiovascular Imaging, the European Society of Cardiology Council on Hypertension and the European Society of Hypertension. J Hypertens. 2017;35:1727–41.
Steeds RP, Garbi M, Cardim N, Kasprzak JD, Sade E, Nihoyannopoulos P, et al. EACVI appropriateness criteria for the use of transthoracic echocardiography in adults: a report of literature and current practice review. Eur Heart J Cardiovasc Imaging. 2017;18:1191–204.
Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561–6.
Modin D, Biering-Sørensen SR, Mogelvang R, Landler N, Jensen JS, Biering-Sørensen T. Prognostic value of echocardiography in hypertensive versus nonhypertensive participants from the general population. Hypertension. 2018;71:742–51.
Yun M, Li S, Yan Y, Sun D, Guo Y, Fernandez C, et al. Blood pressure and left ventricular geometric changes: a directionality analysis. Hypertension. 2021;78:1259–66.
Silbiger JJ. Pathophysiology and echocardiographic diagnosis of left ventricular diastolic dysfunction. J Am Soc Echocardiogr. 2019;32:216–32.e2.
Vaziri SM, Larson MG, Lauer MS, Benjamin EJ, Levy D. Influence of blood pressure on left atrial size. The Framingham Heart Study. Hypertension. 1995;25:1155–60.
Whelton PK, Carey RM, Aronow WS, Casey DE Jr., Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:1269–324.
Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41:1874–2071.
Wei FF, Xue R, Thijs L, Liang W, Owusu-Agyeman M, He X, et al. Associations of left ventricular structure and function with blood pressure in heart failure with preserved ejection fraction: analysis of the TOPCAT trial. J Am Heart Assoc. 2020;9:e016009.
Wei FF, Wu Y, Xue R, Liu X, He X, Dong B, et al. Clinical significance of mean and pulse pressure in patients with heart failure with preserved ejection fraction. Hypertension. 2022;79:241–50.
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–12.
Marwick TH, Gillebert TC, Aurigemma G, Chirinos J, Derumeaux G, Galderisi M, et al. Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE). J Am Soc Echocardiogr. 2015;28:727–54.
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1–39.e14.
Devereux RB, Liebson PR, Horan MJ. Recommendations concerning use of echocardiography in hypertension and general population research. Hypertension. 1987;9:97–104.
Wachtell K, Gerdts E, Aurigemma GP, Boman K, Dahlöf B, Nieminen MS, et al. In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study. Blood Press. 2010;19:169–75.
Kaihara T, Imaizumi Y, Eguchi K, Kario K. Maximum home blood pressure readings are associated with left atrial diameter in essential hypertensives. J Hum Hypertens. 2018;32:432–9.
Cuspidi C, Meani S, Fusi V, Valerio C, Catini E, Sala C, et al. Prevalence and correlates of left atrial enlargement in essential hypertension: role of ventricular geometry and the metabolic syndrome: the Evaluation of Target Organ Damage in Hypertension study. J Hypertens. 2005;23:875–82.
Mureddu GF, Cioffi G, Stefenelli C, Boccanelli A. Relationships of the appropriateness of left ventricular mass to left atrial size and function in arterial hypertension. J Cardiovasc Med. 2007;8:445–52.
Miyoshi H, Oishi Y, Mizuguchi Y, Iuchi A, Nagase N, Ara N, et al. Early predictors of alterations in left atrial structure and function related to left ventricular dysfunction in asymptomatic patients with hypertension. J Am Soc Echocardiogr. 2013;7:206–15.
Agabiti-Rosei E, Muiesan ML. Hypertension and diastolic function. Drugs. 1993;46:61–7.
Ladeiras-Lopes R, Fontes-Carvalho R, Vilela EM, Bettencourt P, Leite-Moreira A, Azevedo A. Diastolic function is impaired in patients with prehypertension: data from the EPIPorto study. Rev Esp Cardiol. 2018;71:926–34.
Kornev M, Caglayan HA, Kudryavtsev AV, Malyutina S, Ryabikov A, Schirmer H, et al. Influence of hypertension on systolic and diastolic left ventricular function including segmental strain and strain rate. Echocardiography. 2023;40:623–33.
de Simone G, Roman MJ, De Marco M, Bella JN, Izzo R, Lee ET, et al. Hemodynamic correlates of abnormal aortic root dimension in an adult population: the strong heart study. J Am Heart Assoc. 2015;4:e002309.
Pedersen MW, Duch K, Lindgren FL, Lundgren NLO, Tayal B, Hagendorff A, et al. Aortic root dimension using transthoracic echocardiography: results from the copenhagen city heart study. Am J Cardiol. 2024;218:86–93.
Canciello G, Mancusi C, Izzo R, Morisco C, Strisciuglio T, Barbato E, et al. Determinants of aortic root dilatation over time in patients with essential hypertension: The Campania Salute Network. Eur J Prev Cardiol. 2021;28:1508–14.
Acknowledgements
We gratefully acknowledge the contribution of all the investigators from participating centers in the Multi-provincial Cohort for Hypertension for data collection.
Funding
This study was supported by National Key Research and Development Program of China(2022YFC3602501); National Natural Science Foundation of China (82073635, 82103962, and 12226005); Beijing municipal medical research institutes pilot reform project (grant number 2023-09) sponsored by Beijing Municipal Health Commission; and Capital Funds for health Improvement and Research (CFH 2024-2G-1052). The funding agencies had no role in the study design; collection, analysis, and interpretation of data; writing of the report; and the decision to submit the report for publication.
Author information
Authors and Affiliations
Contributions
JingL, conceived the design and supervised the work. YQ and JingL critically revised the manuscript. WZ, MW, PZ, ZW, XD, JiangL, NY, LH, and ZY contributed to the acquisition, analysis, or interpretation of data for the work. WZ and MW drafted the manuscript and contribute equally to this manuscript. All gave final approval and agree to be accountable for all aspects of work ensuring integrity and accuracy.
Corresponding authors
Ethics declarations
Ethical approval
This study was approved by the ethics committee of Beijing Anzhen Hospital, Capital Medical University (approval number 2017007), and was conducted in strict accordance with the principles of the Declaration of Helsinki.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zhao, W., Wang, M., Zhou, P. et al. Profiles of echocardiographic features associated with blood pressure in patients with hypertension. J Hum Hypertens 39, 515–522 (2025). https://doi.org/10.1038/s41371-025-01034-4
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/s41371-025-01034-4